![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 11, 2024 12:47:12 PM
*"Empire's take time to build" - CEO
*"Big things happening in 2022" -CEO
*"Very profitable in next 2-3 years"
*listed on TSX in CANADA Jan 20, 2022
*they will be diluting again, they have 23 million in cash right now
*FDA approval - clinical trial starts March 2022, ends in Q3 2023
*Else will be cash positive most likely 2-3 years from now
*expanding scientific advisory board, even more, to help get permit from the FDA
*No plans to split shares on uplisting
*Else does not want to be a manufacturing company but they will own their own equipment.
*Airing a commercial in Q1 2022
*they are going to partner with someone in China and create a team to market there
*Else has about 30-32 total employees
*Yes Srategic partnerships on the horizon, she can't talk about it
* ...
REMINDER: This was more than 2 years ago.
Patiently,
Roger
Recent BABYF News
- Nutrition Firm Expanding into the Fast Growing Kids Market • AllPennyStocks.com • 08/03/2023 04:00:00 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM